Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

GSK plc (GS71)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
16.770 -0.228    -1.34%
18/08 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 63,976
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 16.720 - 17.130
Type:  Equity
Market:  Germany
ISIN:  GB0009252882 
WKN:  940561
GSK plc 16.770 -0.228 -1.34%
IndustryPharmaceuticals
SectorHealthcare
Employees

90096

Equity Type

ORD

GSK plc is a global biopharma company. The Company makes vaccines and specialty medicines to prevent and treat disease. Its segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed a new monoclonal antibody treatment for COVID-19. Its product areas include vaccines, specialty medicines, and general medicines. Its vaccine portfolio includes more than 20 vaccines that help protect people from a range of diseases and infections throughout their lives. Its specialty medicines include medicines for immune-mediated conditions, including the chronic autoimmune condition lupus, respiratory disease, and human immunodeficiency virus (HIV). Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD), antibiotics and medicines for skin diseases. It has a global network of about 12 vaccines manufacturing sites.

Contact Information

Phone 44 20 8047 5000
Fax -

Top Executives

Name Age Since Title
Iain James Mackay 59 2019 CFO & Executive Director
Emma N. Walmsley 51 2011 CEO & Director
Jonathan Richard Symonds 62 2019 Non-Executive Chairman
Vishal Sikka - 2022 Independent Non-Executive Director
Harry C. Dietz 64 2022 Independent Non-Executive Director
Anne C. Beal 60 2021 Independent Non-Executive Director
Jesse L. Goodman 70 2016 Independent Non-Executive Director
Urs Rohner 63 2015 Independent Non-Executive Director
Hal V. Barron 59 2018 Non-Executive Director
Laurie H. Glimcher 70 2017 Independent Non-Executive Director
Charles A. Bancroft 62 2020 Senior Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GSK plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jenny Gough
Jenny Gough Aug 11, 2022 11:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Should have taken the Unilever offer...
Mark Olive
magicpiano Aug 11, 2022 11:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It was madness not to.
Mike Bamber
Mike Bamber Jul 18, 2022 16:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Demerger yet another damp squib in a long line of failures by Walmsley. She is unprecedented in her ability to talk the talk but to not walk the walk!
Anon Anon
Anon Anon Jan 17, 2022 11:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
Anon Anon
Anon Anon Dec 09, 2021 8:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
Will Strath
Will Strath Nov 05, 2021 12:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ex-div in 13 days time. why risk selling now when you might not get back on the boat? pretty sure the company split will reach equivalent of 2000+ for the two new companies.
Craig Nelson
Craig Nelson Nov 05, 2021 9:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1587.80 looking at my previous comment "what do i know" near yearly HIGHS
Anon Anon
Anon Anon Nov 01, 2021 8:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Breakout. Strong buy
Craig Nelson
Craig Nelson Oct 16, 2021 18:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1399.60p described as a good Divi stock but where's the potential capital growth... will wait for sub 1200.00p
Robin Mitha
Robin Mitha Jun 23, 2021 12:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The current CEO seems to have lost confidence, time for a change to inject new life into the company
simon stirling
simon stirling Jun 23, 2021 12:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the news from today remarked that investors present applauded during the event.
Robin Mitha
Robin Mitha Jun 23, 2021 12:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the question is what percentage of GSK shareholders attended, most big investors gont go to such events
simon stirling
simon stirling Jun 23, 2021 12:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
while true, until we know who attended it's hard to gauge lost confidence. at the start of the day pre share holder day, the share price was 20p down, that swung to 40p up at one point, hardly signals negativity
STEPHEN CLARKE
Engweliri Jun 11, 2021 13:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seems to me that a stake is being built, especially from the area of £13.25 upwards. We already have the "activist" investment fund but another buyer is around. Seems similar to whats been happening in BT shares over the last few weeks. Stay long and collect dividends on the way. Hopefully
Mo Ahmadi
Mo Ahmadi Jun 11, 2021 13:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what will happen when the split happens in 2022?!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email